 |
CG Oncology
Arthur Kuan, CEO
USA | Funding: $317.6M (+)
Website: https://www.cgoncology.com/
CG Oncology is developing the next evolution of oncolytic immunotherapy for patients with advanced cancers.
Website: https://www.cgoncology.com/
CG Oncology is developing the next evolution of oncolytic immunotherapy for patients with advanced cancers.
